© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
Physio-pharmacological evaluation of myocardial performance: an integrative approach
aDepartment of Cardiology, University of Wales College of Medicine, Heath Park, Cardiff, CF4 FXN, UK
bLaboratory of Cardiovascular Science, Gerontology Research Center, NIA, National Institutes of Health, Baltimore, USA
* Corresponding author. Tel.: +44 1222 742338; Fax: +44 1222 743500; E-mail: shaham2@cf.ac.uk
Received 16 March 1998; accepted 17 March 1998
KEYWORDS Contractive function; Endothelial function; Myocytes; Ventricular function
| The first 150 words of the full text of this article appear below. |
Despite major advances in the understanding of cardiovascular physiology and pathophysiology and the development of new therapies in the 20th century, cardiovascular disease is projected to become the leading overall cause of mortality worldwide within the next couple of decades [1]. In the western world, an increasing proportion of older people in the population accounts for the lack of reduction in the absolute number of cardiovascular deaths, whereas in developing countries, part of the reason is the adoption of "western" lifestyles and their accompanying coronary risk factors as socioeconomic status gradually improves and mortality from infectious and other diseases of early life decrease. There remain significant gaps in our understanding of many aspects of cardiovascular diseases and the contribution of risk factors such as smoking, hypercholesterolaemia, hypertension and diabetes. In addition, increasing numbers of patients who survive ischaemic cardiac disorders develop heart failure.
Traditionally, the focus of research into
| 1 The isolated heart |
|---|
| 2 Isolated papillary muscle and trabecular preparations |
|---|
| 3 Isolated cardiac myocytes |
|---|
| 4 Subcellular model systems |
|---|
| 5 The use of animal models |
|---|
| 6 Conclusions |
|---|